MiRNAs: potential diagnostic and therapeutic targets for cerebral ischaemia

References

• Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011;42:3651–4.10.1161/STROKEAHA.111.635755
   PubMed Web of Science ®Google Scholar
• Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6:456–64.10.1016/S1474-4422(07)70004-2
   PubMed Web of Science ®Google Scholar
• Jia Q, Liu LP, Wang YJ. Stroke in China. Clin Exp Pharmacol Physiol. 2010;37:259–64.10.1111/cep.2010.37.issue-2
   PubMed Web of Science ®Google Scholar
• Domingues-Montanari S, Mendioroz M, del Rio-Espinola A, Fernández-Cadenas I, Montaner J. Genetics of stroke: a review of recent advances. Expert Rev Mol Diagn. 2008;8:495–513.10.1586/14737159.8.4.495
   PubMed Web of Science ®Google Scholar
• Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute cerebral ischemia. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.10.1161/01.STR.24.1.35
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011;717(1–2):1–8.10.1016/j.mrfmmm.2011.03.009
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102–14.10.1038/nrg2290
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–5.10.1038/nature02871
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell. 2005;120(1):15–20.10.1016/j.cell.2004.12.035
   PubMed Web of Science ®Google Scholar
• Rink C, Khanna S. MicroRNA in cerebral ischemia etiology and pathology. Physiol Genomics. 2011;43:521–8.10.1152/physiolgenomics.00158.2010
   PubMed Web of Science ®Google Scholar
• Tan JR, Koo YX, Kaur P, Liu F, Armugam A, Wong PT, et al. microRNAs in stroke pathogenesis. Curr Mol Med. 2011;11:76–92.10.2174/156652411794859232
   PubMed Web of Science ®Google Scholar
• Vickers KC, Remaley AT. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr Opin Endocrinol Diabetes Obes. 2010;17(2):150–5.10.1097/MED.0b013e32833727a1
   PubMedGoogle Scholar
• Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA. 2008;105(5):1516–21.10.1073/pnas.0707493105
   PubMed Web of Science ®Google Scholar
• Weber M, Baker MB, Moore JP, Searles CD. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun. 2010;393(4):643–8.10.1016/j.bbrc.2010.02.045
   PubMed Web of Science ®Google Scholar
• Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2009;104:476–87.10.1161/CIRCRESAHA.108.185363
   PubMed Web of Science ®Google Scholar
• Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009;324:1710–3.10.1126/science.1174381
   PubMed Web of Science ®Google Scholar
• Cheng YH, Liu XJ, Yang J, Lin Y, Xu DZ, Lu Q, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009;105:158–66.10.1161/CIRCRESAHA.109.197517
   PubMed Web of Science ®Google Scholar
• Fasanaro P, D’Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, et al. MicroRNA-210 modulatesendothelial cell response to hypoxia and inhibits the receptor tyrosinekinase ligand Ephrin-A3. J Biol Chem. 2008;283:15878–83.10.1074/jbc.M800731200
   PubMed Web of Science ®Google Scholar
• Sacco J, Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–9.
   PubMed Web of Science ®Google Scholar
• Rashidian J, Iyirhiaro G, Aleyasin H, Rios M, Vincent I, Callaghan S, et al. Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci USA. 2005;102:14080–5.10.1073/pnas.0500099102
   PubMed Web of Science ®Google Scholar
• Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, et al. Susceptibility to coronary artery disease and diabetesis encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet. 2008;17:806–14.
   PubMed Web of Science ®Google Scholar
• Adeli K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol. 2012;23(3):220–5.
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328(5985):1570–3.10.1126/science.1189862
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature. 2011;478(7369):404–7.10.1038/nature10486
   PubMed Web of Science ®Google Scholar
• Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of lipid metabolism revealed by in vivoantisense targeting. Cell Metab. 2006;3(2):87–98.10.1016/j.cmet.2006.01.005
   PubMed Web of Science ®Google Scholar
• Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S, et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res. 2009;83:131–9.10.1093/cvr/cvp121
   PubMed Web of Science ®Google Scholar
• Ono K, Horie T, Nishino T, Baba O, Kuwabara Y, Kimura T. MicroRNAs and high-density lipoprotein cholesterol metabolism. Int Heart J. 2015;56(4):365–71.10.1536/ihj.15-019
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Moore KJ. MicroRNA control of high-density lipoprotein metabolism and function. Circ Res. 2014;114(1):183–9.10.1161/CIRCRESAHA.114.300645
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res. 2010;51(6):1513–23.10.1194/jlr.M004812
   PubMed Web of Science ®Google Scholar
• Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P, et al. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens. 2011;24(2):241–6.10.1038/ajh.2010.211
   PubMed Web of Science ®Google Scholar
• Wei Z, Biswas N, Wang L, Courel M, Zhang K, Soler-Jover A, et al. A common genetic variant in the 3′-UTR of vacuolar H+-ATPase ATP6V0A1 creates a micro-RNA motif to alter chromogranin A processing and hypertension risk. Circ Cardiovasc Genet. 2011;4(4):381–9.10.1161/CIRCGENETICS.111.959767
   PubMed Web of Science ®Google Scholar
• Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation. 2011;124:175–84.10.1161/CIRCULATIONAHA.110.012237
   PubMed Web of Science ®Google Scholar
• Santovito D, Mandolini C, Marcantonio P, De Nardis V, Bucci M, Paganelli C, et al. Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets. 2013;17:217–23.10.1517/14728222.2013.745512
   PubMed Web of Science ®Google Scholar
• Eskildsen TV, Jeppesen PL, Schneider M, Nossent AY, Sandberg MB, Hansen PB, et al. Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci. 2013;14:11190–207.10.3390/ijms140611190
   PubMed Web of Science ®Google Scholar
• Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 2008;39(3):959–66.10.1161/STROKEAHA.107.500736
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs inserum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997–1006.10.1038/cr.2008.282
   PubMed Web of Science ®Google Scholar
• Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW, et al. Expression profile of MicroRNAs in young stroke patients. PLoS ONE. 2009;4:e7689.10.1371/journal.pone.0007689
   PubMed Web of Science ®Google Scholar
• Tan JR, Tan KS, Koo YX, Yong FL, Wang CW, Armugam A, et al. Blood microRNAs in low or no risk cerebral ischemia patients. Int J Mol Sci. 2013;14:2072–84.10.3390/ijms14012072
   PubMed Web of Science ®Google Scholar
• Li P, Teng F, Gao F, Zhang M, Wu J, Zhang C. Identification of circulating MicroRNAs as potential biomarkers for detecting acute cerebral ischemia. Cell Mol Neurobiol. 2015;35(3):433–47.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang J, Han R, Liu H, Sun D, Liu X. Downregulation of serum brain specific microRNA is associated with inflammation and infarct volume in acute cerebral ischemia. J Clin Neurosci. 2015;22(2):291–5.10.1016/j.jocn.2014.05.042
   PubMed Web of Science ®Google Scholar
• Jickling GC, Ander BP, Zhan X, Noblett D, Stamova B, Liu D. microRNA expression in peripheral blood cells following acute cerebral ischemia and their predicted gene targets. PLoS ONE. 2014;9(6):e99283.10.1371/journal.pone.0099283
   PubMed Web of Science ®Google Scholar
• Long G, Wang F, Li H, Yin Z, Sandip C, Lou Y, et al. Circulating miR-30a, miR-126 and let-7b as biomarker for cerebral ischemia in humans. BMC Neurol. 2013;13(1):178–187.10.1186/1471-2377-13-178
   PubMed Web of Science ®Google Scholar
• Zeng L, Liu J, Wang Y, Wang L, Weng S, Tang Y, et al. microRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci. 2011;3:1265–72.
   Google Scholar
• Siegel C, Li J, Liu F, Benashski SE, McCullough LD. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA. 2011;108:11662–7.10.1073/pnas.1102635108
   PubMed Web of Science ®Google Scholar
• Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol. 2009;578:3–22.10.1007/978-1-60327-411-1
   PubMedGoogle Scholar
• Duan RH, Pak CH, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet. 2007;16(9):1124–31.10.1093/hmg/ddm062
   PubMed Web of Science ®Google Scholar
• Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389–402.10.1038/nrc2867
   PubMed Web of Science ®Google Scholar
• Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA. 2007; 104(9):3300–5.10.1073/pnas.0611347104
   PubMed Web of Science ®Google Scholar
• Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat. 2012;33:254–263.10.1002/humu.21641
   PubMed Web of Science ®Google Scholar
• Jeon YJ, Kim OJ, Kim SY, Oh SH, Oh D, Kim OJ, et al. Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with cerebral ischemia and silent brain infarction risk. Arterioscler Thromb Vasc Biol. 2012;33:420–30.
   PubMed Web of Science ®Google Scholar
• Zhu R, Liu X, He Z, Li Q. miR-146a and miR-196a2 polymorphisms in patients with cerebral ischemia in the northern Chinese Han population. Neurochem Res. 2014;39(9):1709–16.10.1007/s11064-014-1364-5
   PubMed Web of Science ®Google Scholar
• Huang S, Zhou S, Zhang Y, Lv Z, Li S, Xie C, et al. Association of the genetic polymorphisms in pre- microRNAs with risk of cerebral ischemia in a Chinese population. PLOS ONE. 2015;10(2):e0117007.10.1371/journal.pone.0117007
   Google Scholar
• Liu Y, Ma Y, Zhang B, Wang SX, Wang XM, Yu JM. Genetic polymorphisms in pre-microRNAs and risk of cerebral ischemia in a Chinese population. J Mol Neurosci. 2014;52(4):473–80.10.1007/s12031-013-0152-z
   PubMed Web of Science ®Google Scholar
• Yuan M, Zhan Q, Duan X, Song B, Zeng S, Chen X, et al. A functional polymorphism at miR-491-5p binding site in the 3′-UTR of MMP-9 gene confers increased risk for atherosclerotic cerebral infarction in a Chinese population. Atherosclerosis. 2013;226(2):447–52.10.1016/j.atherosclerosis.2012.11.026
   PubMed Web of Science ®Google Scholar
• Liu ME, Liao YC, Lin RT, Wang YS, Hsi E, Lin HF, et al. A functional polymorph ism of PON1 interfer es with microRNA binding to increase the risk of cerebral ischemia and carotid atherosclerosis. Atherosclerosis. 2013;228(1):161–7.10.1016/j.atherosclerosis.2013.01.036
   PubMed Web of Science ®Google Scholar
• Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, et al. Circulating microrna-208b and microrna-499 reflect myocardial damage in cardiovascular disease/clinical perspective. Circulation: cardiovascular. Genetics. 2010;3(6):499–506.
   Web of Science ®Google Scholar
• Jeyaseelan K, Herath WB, Armugam A. MicroRNAs as therapeutic targets in human diseases. Expert Opin Ther Targets. 2007;11(8):1119–29.10.1517/ett.2007.11.issue-8
   PubMed Web of Science ®Google Scholar
• Wu P, Zuo X, Ji A. Stroke-induced microRNAs: the potential therapeutic role for stroke. Exp Ther Med. 2012;3(4):571–6.
   PubMed Web of Science ®Google Scholar
• Ouyang YB, Stary CM, Yang GY, Giffard R. microRNAs: innovative targets for cerebral ischemia and stroke. Curr Drug Targets. 2013;14(1):90–101.10.2174/138945013804806424
   PubMed Web of Science ®Google Scholar
• Buller B, Liu X, Wang X, Zhang RL, Zhang L, Hozeska-Solgot A, et al. MicroRNA-21 protects neurons from ischemic death. FEBS J. 2010;277(20):4299–307.10.1111/j.1742-4658.2010.07818.x
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature. 2005;438(7068):685–9.10.1038/nature04303
   PubMed Web of Science ®Google Scholar
• Nunnari G, Schnell MJ. MicroRNA-122: a therapeutic target for hepatitis C virus (HCV) infection. Front Biosci (Schol Ed). 2011; 3(1):1032–7.10.2741/207
   PubMedGoogle Scholar
• Selvamani A, Sathyan P, Miranda RC, Sohrabji F. An antagomir to microRNA Let7f promotes neuroprotection in an cerebral ischemia model. PLoS ONE. 2012;7(2):e32662.10.1371/journal.pone.0032662
   Google Scholar
• Ouyang YB, Lu Y, Yue S, Xu LJ, Xiong XX, White RE, et al. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis. 2012;45(1):555–63.10.1016/j.nbd.2011.09.012
   PubMed Web of Science ®Google Scholar
• Yin KJ, Deng Z, Huang H, Hamblin M, Xie C, Zhang J, et al. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 2010;38(1):17–26.10.1016/j.nbd.2009.12.021
   PubMed Web of Science ®Google Scholar
• Sepramaniam S, Armugam A, Lim KY, Karolina DS, Swaminathan P, Tan JR, et al. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J Biol Chem. 2010;285(38):29223–30.10.1074/jbc.M110.144576
   PubMed Web of Science ®Google Scholar
• Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009;324:1710–3.10.1126/science.1174381
   PubMed Web of Science ®Google Scholar
• Selvamani A, Sathyan P, Miranda RC, Sohrabji F. An antagomir to MicroRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS ONE. 2012;7(2):e32662.10.1371/journal.pone.0032662
   Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13(4):423–33.10.1038/ncb2210
   PubMed Web of Science ®Google Scholar
• van Rooij E, Purcell AL, Levin AA. Developing MicroRNA therapeutics. Circ. Res. 2012;110(3):496–507.10.1161/CIRCRESAHA.111.247916
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O’Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137:1005–17.10.1016/j.cell.2009.04.021
   PubMed Web of Science ®Google Scholar